shangrilabio
Anti-cancer NKT Immune cell therapy
- HOME
- R&D
- Research
- Anti-cancer NKT Immune cell therapy
NKT Immune cell therapy
Characteristics of NKT cells and unique core technology for anticancer immune cell therapy
- Treatment Process
- 1. Apheresis of the patient's peripheral blood monocytes
- 2. Produce a cell vaccine that activates NKT cells
- 3. Administration to patients to induce anticancer immune cell therapy
- Development
- Manufacture economical and efficient anticancer cell treatment by shortening the cell treatment process time
- Core technology to secure safety
- Safety of patient's cell use (autotransplantation)
- Compared to gene therapy products (CAR-T, CAR-NK cell therapy), which have recently become an issue, there is no gene manipulation, so a safer and simpler cell treatment process
Milestone
